Immune Response BioPharma Sets Pricing of REMUNE Vaccine in Thailand Between $75 -100 Per Dose
5/20/2013
More...
|
EMD Millipore Launches OsteoMAX-XF™, a Fully-Defined, Xeno-Free Mesenchymal Stem Cell Osteogenic Differentiation Medium
5/9/2013
More...
|
Merck & Co., Inc. (MRK), GlaxoSmithKline (GSK) Reduce HPV Vaccine Prices by 95 Pct. in Poorest Regions
5/9/2013
More...
|
Non Profit to Bayer AG (BAY.F): Withdraw False Vitamin Claims or Else!
5/9/2013
More...
|
BioTie Therapies Corp.: Selincro Launched in the United Kingdom
5/6/2013
More...
|
BioTie Therapies Corp.: Selincro Launched in the United Kingdom
5/6/2013
More...
|
Retractions?! Conflicts?! Novartis AG (NVS) Probes Diovan Research
5/3/2013
More...
|
Martindale Pharma® Launches Tapclob®, the First Licensed Oral Liquid Suspension of Clobazam
5/1/2013
More...
|
EMD Millipore Launches OsteoMAX-XF™, a Fully Defined, Xeno-free Mesenchymal Stem Cell Osteogenic Differentiation Medium
4/30/2013
More...
|
BioTie Therapies Corp.: Selincro Launched in First European Markets
4/22/2013
More...
|
Cipla Ltd. Launches Shanghai CP Guojian's Biosimilar in India
4/19/2013
More...
|
GlaxoSmithKline (GSK)'s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment
4/18/2013
More...
|
European Medicines Agency Staff Push to Restrict Servier Osteoporosis Drug
4/15/2013
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)'s Withdraws Muscle Relaxant From the U.S.
4/11/2013
More...
|
GW Pharmaceuticals' Cannabinoid-Medicine Sativex® Moved to Schedule 4 of UK Drugs Act
4/10/2013
More...
|
Novartis AG (NVS) Blockbuster Linked to Retracted Papers
4/2/2013
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Zenatane™ (Isotretinoin Capsules USP)
3/29/2013
More...
|
Pharming Group (PHGUF.PK) Announces European Medicines Agency Approval of New Manufacturing Site for Ruconest®
3/28/2013
More...
|
National Institute for Clinical Excellence (NICE) Issues Draft "No" for Pfizer Inc. (PFE)'s Xalkori, but Opens Consultation
3/28/2013
More...
|
FDA Perspective Published in The New England Journal of Medicine Reinforces Safety of Boehringer Ingelheim Corporation's Pradaxa® (dabigatran etexilate)
3/26/2013
More...
|
BASF Increases Prices for N,N-Dimethylformamide
3/25/2013
More...
|
FDA Denies Approval for GlaxoSmithKline (GSK) Bird Flu Vaccine
3/25/2013
More...
|
GW Pharmaceuticals, Almirall May Pull Cannabis Drug in German Price Row
3/20/2013
More...
|
Sanofi (France) (SAN.PA): U.S. Probes Disclosures to FDA About Patient Response to Plavix
3/11/2013
More...
|
Novartis AG (NVS), Roche (RHHBY) Accused by Italy of Eye Drug "Cartel"
2/22/2013
More...
|
R-Tech Ueno: Announcement of Commercial Availability of RESCULA® Eye Drops in the U.S. Market
2/21/2013
More...
|
Novartis AG (NVS)'s Jakavi Turned Down by National Institute for Clinical Excellence (NICE) for Blood Cancer
2/13/2013
More...
|
Ipsen (IPN.PA) Release: Eziclen® / Izinova® a New Product for Bowel Cleansing Successfully Completed European Decentralised Registration Procedure
2/7/2013
More...
|
Luqa Pharmaceuticals Launches Strataderm® in China
2/1/2013
More...
|
UK's National Institute for Clinical Excellence (NICE) Rejects Genentech (RHHBY)'s Avastin for Ovarian Cancer
2/1/2013
More...
|
European Commission (EC) Charges Johnson & Johnson (JNJ) and Novartis AG (NVS) With Pay-to-Delay
1/31/2013
More...
|
GlaxoSmithKline (GSK) Vaccine Linked to 800 Children Narcolepsy Cases in EU
1/28/2013
More...
|
AGNSS Recommends Alexion Pharmaceuticals Inc. (ALXN)'s Soliris® (eculizumab) for aHUS and Concludes "Eculizumab Would Help Save Lives and Improve the Quality of Life for Children and Adults With Atypical Haemolytic Uraemic Syndrome"
1/24/2013
More...
|
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE) Drug Wins National Institute for Clinical Excellence (NICE) Nod for Irregular Heartbeats
1/23/2013
More...
|
Teijin Pharma to Launch Ipsen (IPN.PA)'s Somatuline® Subcutaneous Injection in the Treatment of Acromegaly and Pituitary Gigantism in Japan
1/17/2013
More...
|
India Takes Another Swipe at Big Pharmas Such as Bristol-Myers Squibb Company (BMY), Roche (RHHBY); Govt. to Make 3 Key CA Drugs Cheaper
1/14/2013
More...
|
Journal Refuses to Retract GlaxoSmithKline (GSK)'s Controversial Paxil Study
1/10/2013
More...
|
Forest Laboratories, Inc. (FRX) and Almirall Announce Commercial Availability of Tudorza™ Pressair™ in U.S. Pharmacies
12/11/2012
More...
|
National Institute for Clinical Excellence (NICE) Says "No" on Pfizer Inc. (PFE) Kidney Cancer Drug
12/7/2012
More...
|
Tanzania Expands Immunization Program to Include Pfizer Inc. (PFE)'s Prevenar 13 for Prevention of Pneumococcal Disease
12/5/2012
More...
|
curasan AG (DX:CUR) Now Sells Bone Regeneration Material in Injectable Form
12/5/2012
More...
|
Sucampo Pharmaceuticals, Inc. and Abbott Laboratories (ABT) Announce Launch of AMITIZA in Japan
11/26/2012
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of SILDENAFIL TABLETS
11/19/2012
More...
|
Bayer AG (BAY.F) Bets $4 Billion on R8D and Sales From 5 Blockbuster Drugs
11/14/2012
More...
|
Roche (RHHBY) Fails to Address Question of Missing Tamiflu Data
11/14/2012
More...
|
Sanofi (France) (SAN.PA) Halves Price of Cancer Drug After Rejection From Cancer Center
11/9/2012
More...
|
National Institute for Clinical Excellence (NICE) Rejects Novartis AG (NVS) Asthma Drug in Change of Tack
11/9/2012
More...
|
Cipla Ltd. Slashes Cancer Drug Prices by Up to 64 Pct
11/8/2012
More...
|
AstraZeneca PLC (AZN), PTSD and a Buried Seroquel Study
11/8/2012
More...
|
British Medical Journal Pushes Roche (RHHBY) for Raw Data on Tamiflu Trials
10/31/2012
More...
|
Phagenesis Ltd Launches First Treatment for Acute Dysphagia
10/25/2012
More...
|
NicOx SA (COX.PA) Launches AdenoPlus™ in the United States
10/22/2012
More...
|
National Institute for Clinical Excellence (NICE) Stroke Guidance Boost for Boehringer Ingelheim Corporation's Actilyse
10/16/2012
More...
|
Tarsa Therapeutics to Assist Therapicon in Its Challenge to CHMP's Recommendation to Limit Use of Calcitonin
10/12/2012
More...
|
National Institute for Clinical Excellence (NICE) U-turns on Novartis AG (NVS)'s Lucentis for Diabetic Macular Oedema
10/5/2012
More...
|
Dr. Reddy's Laboratories Ltd. (RDY) Announces the Launch of Montelukast Sodium Oral Granules
9/27/2012
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Misses Out on First-Day Launch of Hypertension Drug's Generic Version
9/26/2012
More...
|
Dueling Tests Pressure Roche (RHHBY) Bet on Herceptin
9/24/2012
More...
|
Orexo AB Presents an Update on the U.S. Opioid Dependence Market, and the Commercial Opportunities for Zubsolv™ (OX219)
9/21/2012
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Amoxicillin Tablets, Capsules, and Oral Suspension
9/20/2012
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Announces China Government-Mandated ZADAXIN® Price Reduction; Anticipates Minimal Impact on Revenue and Margins
9/18/2012
More...
|
Medivation, Inc. (MDVN) and Astellas Pharma Inc. (YPH.BE) Announce XTANDI® (Enzalutamide) is Now Available for Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
9/13/2012
More...
|
Dr. Reddy's Laboratories Ltd. (RDY) Announces the Launch of Metoprolol Succinate ER (Extended-Release) Tablets
9/11/2012
More...
|
Healthcare Watchdog to Reconsider GlaxoSmithKline (GSK) Drug Benlysta Following Drugmaker's Appeal
9/10/2012
More...
|
Brazil Seizes Fake Schering-Plough Corporation (SGP) Products
9/4/2012
More...
|
Wockhardt Launches Generic Version of Anti-Depressant Drug Wellbutrin® SR
9/4/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Steps Up Defence of Key MS Drug
9/4/2012
More...
|
Glenmark Pharmaceuticals Wins Right to Sell HIV Diarrhea Drug in 140 Countries
8/23/2012
More...
|
Roche (RHHBY)'s Avastin Strikes Out Again With National Institute for Clinical Excellence (NICE)
8/23/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch of Generic ACTOplus met® in the United States
8/20/2012
More...
|
Amgen (AMGN)'s Xgeva Gains National Institute for Clinical Excellence (NICE) Recommendation for Bone Metastasis
8/17/2012
More...
|
Eisai Inc. (ESALF.PK) CEO Sees "Huge" Medical Need for New Diet Drug
8/15/2012
More...
|
Roche (RHHBY) Requested by National Institute for Clinical Excellence (NICE) to Provide Further Zelboraf Data
8/13/2012
More...
|
Did Ranbaxy Laboratories (RANBAXY.BO) Abandon Generic Provigil Launch?
8/8/2012
More...
|
Melbourn Scientific First to Offer FDA Approved Spray Pattern and Plume Geometry Analysis
8/1/2012
More...
|
Novartis AG (NVS) Resumes Production of Excedrin
7/26/2012
More...
|
UK Authority Backs Down in Novartis AG (NVS) Eye Drug Dispute
7/26/2012
More...
|
National Institute for Clinical Excellence (NICE) Recommends Bayer AG (BAY.F)'s Xarelto
7/25/2012
More...
|
UCB, Inc. (UCBJF.PK) Launches Neupro® in the U.S. to Treat Parkinson's Disease and Restless Legs Syndrome
7/16/2012
More...
|
Sanofi (France) (SAN.PA)'s Sleep Driving Drug Should Remain on the Shelves Says Australian Therapeutic Goods Administration
7/10/2012
More...
|
UK Rejects Roche (RHHBY)'s Avastin in Advanced Breast Cancer
7/9/2012
More...
|
Astellas Pharma Inc. (YPH.BE) and XenoPort, Inc. (XNPT) Announce the Launch of Regnite® Tablets for Restless Legs Syndrome in Japan
7/9/2012
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Ibandronate Sodium Tablets
7/2/2012
More...
|
InterMune, Inc. (ITMN) Release: Sweden's Dental and Pharmaceutical Benefits Agency (TLV) Authorizes Reimbursement of Esbriet® (pirfenidone)
6/29/2012
More...
|
Heart Risk Seen With GlaxoSmithKline (GSK)'s Zofran?
6/29/2012
More...
|
MEDA: Zyclara Receives Positive Opinion from the Committee for Human Medicinal Products in the European Union
6/25/2012
More...
|
European Medicines Agency Clears Roche (RHHBY) Cancer Drug MabThera
6/21/2012
More...
|
National Institute for Clinical Excellence (NICE) Rejects Use of Roche (RHHBY)'s Melanoma Drug Zelboraf
6/18/2012
More...
|
Amgen (AMGN)'s Xgeva Wins U.K. National Institute for Clinical Excellence (NICE) Backing for Some Cancer Patients
6/12/2012
More...
|
Roche Holding AG (RHHBF.PK)'s Injectable Boniva Med is in Short Supply
6/8/2012
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Ropinirole Hydrochloride XR (Extended-Release) Tablets
6/7/2012
More...
|
UK's National Institute for Clinical Excellence (NICE) Recommends Johnson & Johnson (JNJ)'s Xarelto for Treating Blood Clots
6/1/2012
More...
|
Supplies of Maalox Dwindling Across Canada Caused by Novartis AG (NVS) Shutdown
5/31/2012
More...
|
Cytori Therapeutics, Inc. (CYTX) Obtains Celution(R) Approval in Russia; to Launch Product Line for Plastic Surgery and Select Soft Tissue Therapies
5/30/2012
More...
|
European Medicines Evaluation Agency Clears Roche (RHHBY) Cancer Drug MabThera
5/29/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Decides Not to Launch Generic Lipitor
5/29/2012
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Plans to Relaunch Skin Drug in the US
5/21/2012
More...
|
Dr. Reddy's Laboratories Ltd. (RDY) Announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules
5/21/2012
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Clopidogrel Tablets, USP
5/18/2012
More...
|
National Institute for Clinical Excellence (NICE) Reverses Earlier Decision, Backs Johnson & Johnson (JNJ)'s Zytiga
5/16/2012
More...
|
National Institute for Clinical Excellence (NICE) Backs Allergan Inc. (AGN)''s Botox for Some Migraine Sufferers
5/11/2012
More...
|
Roche (RHHBY) Wins UK National Institute for Clinical Excellence (NICE) Backing for Tarceva in Advanced Lung Cancer
5/10/2012
More...
|
Teijin Pharma's Febuxostat (FEBURIC) Launches in Taiwan - Novel Drug for Treatment of Hyperuricemia With Gout
5/10/2012
More...
|
Meda AB (MEDA-A.ST): Dymista – Could be the Drug of Choice
5/4/2012
More...
|
Cipla Ltd. Makes Cancer Drug Cheaper
5/3/2012
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Creates India's First New Drug
4/30/2012
More...
|
BASF Relocates Production of Kolliphor TPGS to its Minden Site
4/30/2012
More...
|
Pharmaxis Ltd (PXS.AX) Receives Approval to Market Bronchitol in the EU
4/27/2012
More...
|
GlaxoSmithKline (GSK) Attacks National Institute for Clinical Excellence (NICE) for Rejecting New Lupus Treatment
4/27/2012
More...
|
Swiss Insurers Agree to Reimburse Clinuvel's SCENESSE® for Rare Disease
4/26/2012
More...
|
Novartis AG (NVS) Tries to Make UK Hospitals Use $1000 Drug Vs. Roche (RHHBY)'s $97 Avastin
4/26/2012
More...
|
Novartis AG (NVS)'s Gilenya Given Final Approval by UK's Cost Agency
4/25/2012
More...
|
Affymax, Inc. (AFFY) and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Release: OMONTYS® (Peginesatide) Injection Now Available for Adult Chronic Kidney Disease (CKD) Patients on Dialysis in the United States
4/24/2012
More...
|
Consumer Group to FDA: Pull Novo Nordisk A/S (NVO)'s Victoza Off the Market
4/23/2012
More...
|
European Medicines Evaluation Agency Supports Novartis AG (NVS)' Gilenya With Stronger Warning
4/20/2012
More...
|
Boehringer Ingelheim Corporation Release: GLORIATM-AF Registry Program Investigating Use of Antithrombotic Therapy in 56,000 Patients with Atrial Fibrillation at Risk of Stroke Announced
4/20/2012
More...
|
Eisai Company, Ltd. (ESALY.PK) to Launch Insomnia Treatment Lunesta(R) in Japan
4/18/2012
More...
|
Roche (RHHBY)'s Avastin Rejected by National Institute for Clinical Excellence (NICE) for Use in Breast Cancer
4/18/2012
More...
|
Sucampo Pharmaceuticals, Inc. and Clinigen Announce Named Patient Program for European Union, Iceland and Norway to Provide Access to AMITIZA® (lubiprostone) for Chronic Idiopathic Constipation Patients
4/18/2012
More...
|
Novartis AG (NVS)'s Gilenya Patient Develops Rare Brain Disease
4/16/2012
More...
|
Abbott Laboratories (ABT) Humira Tops Sales as Lipitor, Plavix Era Ends
4/13/2012
More...
|
Novo Nordisk A/S (NVO) Says Diabetes Drug Victoza Superior to Merck & Co., Inc. (MRK)'s Januvia
4/9/2012
More...
|
Pfizer Inc. (PFE)'s Rimadyl Alarms Vets in the UK
4/9/2012
More...
|
Sanofi (France) (SAN.PA)'s Ambien Lawsuit & a Hard Rock Exec's Death
4/5/2012
More...
|
FDA Finds More Fake Batches of Roche (RHHBY)'s Avastin Cancer Drug in U.S.
4/4/2012
More...
|
Eisai Company, Ltd. (ESALY.PK)'s Halaven Breast-Cancer Drug Rejected by National Institute of Clinical Research
4/3/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch of Generic Avapro® and Generic Avalide® in the United States; Awarded 180-Day Period of Marketing Exclusivity
4/2/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch of Authorized Generic of Provigil®
3/30/2012
More...
|
National Institute for Clinical Excellence (NICE) Okays Bayer AG (BAY.F)'s Genentech Xarelto In Stroke Prevention
3/30/2012
More...
|
Boehringer Ingelheim Corporation Cuts Pradaxa Price by 13 Percent in the UK
3/29/2012
More...
|
Roche (RHHBY) Cuts the Price of Cancer Drugs in India - Under Pressure?
3/29/2012
More...
|
Roche Holding AG (RHHBF.PK) to Sell Cheaper Cancer Drugs in India
3/26/2012
More...
|
National Institute for Clinical Excellence (NICE) Backs Novartis AG (NVS) MS Drug, Overturning Earlier Decision
3/19/2012
More...
|
Johnson & Johnson (JNJ) Hepatitis C Drug Wins Backing From UK's National Institute for Clinical Excellence (NICE)
3/16/2012
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) Says Its Eye Drug is Taking Roche (RHHBY) Patients
3/16/2012
More...
|
Boehringer Ingelheim Corporation's Pradaxa Wins UK Agency's Backing in Stroke
3/15/2012
More...
|
Pharma Industry Split Over Nod to Natco Pharma Limited to Sell Bayer AG (BAY.F)'s Cancer Drug; Verdict Opens Door for Cheaper Drugs
3/13/2012
More...
|
FDA Rejects AstraZeneca PLC (AZN) Move on Generic Seroquel
3/9/2012
More...
|
National Institute for Clinical Excellence (NICE) Backs Merck & Co., Inc. (MRK) Hepatitis C Drug Victrelis
3/9/2012
More...
|
Novartis AG (NVS)' Gilenya Pill Loses Market Share as Doctors Become Wary
3/7/2012
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Launches Generic Atorvastatin in European Markets
3/6/2012
More...
|
Dr. Reddy's Laboratories, Inc. (RDY)’s Announces the Launch of Ziprasidone Hydrochloride Capsules
3/5/2012
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch of Generic Prometrium® Capsules in the United States
3/2/2012
More...
|
Fake Avastin Lacked Active Ingredient: Roche (RHHBY)
2/28/2012
More...
|
National Institute for Clinical Excellence (NICE) Backs Earlier Use of Roche (RHHBY)'s Arthritis Therapy RoActemra
2/22/2012
More...
|
Mylan Inc. (MYL) to Launch Generic Copaxone in H2 2013
2/22/2012
More...
|
European Medicines Evaluation Agency Decides Risk of Roche (RHHBY)'s Xenical and GlaxoSmithKline (GSK)'s Alli Diet Drug are OK
2/20/2012
More...
|
National Institute for Clinical Excellence (NICE) Not Convinced Allergan Inc. (AGN)'s Botox Can be Used for Migraines
2/16/2012
More...
|
National Institute for Clinical Excellence (NICE) Rejects GlaxoSmithKline (GSK) and Roche (RHHBY) Breast Cancer Meds
2/14/2012
More...
|
Medivir AB (MVIRb.F)’s Partner GlaxoSmithKline (GSK) Initiates OTC Launch of Xerclear® in Europe under Trade Names Zoviduo and Zovirax Duo
2/8/2012
More...
|
National Institute for Clinical Excellence (NICE) Rejects Use of Johnson & Johnson (JNJ)'s Prostate Cancer Drug Zytiga
2/2/2012
More...
|
FDA Panel Wants Suicide Risk on Novartis AG (NVS) ADHD Drug Label
2/1/2012
More...
|
FDA Chides Celgene (CELG), Novartis AG (NVS) on Drug Promotion
1/26/2012
More...
|
National Institute for Clinical Excellence (NICE) Backs Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Eliquis
1/25/2012
More...
|
28 Deaths in Pakistan Due to Suspected Drugs Reaction, Pharmaceutical Factory Sealed
1/24/2012
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB), Elan Corporation PLC (ELN) Win FDA Approval of Label Change for Tysabri
1/24/2012
More...
|
Novartis AG (NVS)'s Gilenya Reviewed by EU After 11 Patient Deaths
1/23/2012
More...
|
Novartis AG (NVS) Announces China Launch for Lucentis and Galvus
1/18/2012
More...
|
Roche (RHHBY) Refuses to Disclose Tamiflu Data: Scientists
1/18/2012
More...
|
National Institute for Clinical Excellence (NICE) Backs Novartis AG (NVS)'s Tasigna for CML, Rejects Bristol-Myers Squibb Company (BMY)'s Sprycel
1/16/2012
More...
|
UK Body Recommends Eli Lilly and Company (LLY), Amylin Pharmaceuticals, Inc. (AMLN) Diabetes Drug Bydureon
1/16/2012
More...
|
UK's National Institute for Clinical Excellence (NICE) Says No to Sanofi (France) (SAN.PA) Prostate Cancer Drug
1/16/2012
More...
|
Pfizer Inc. (PFE) Contraceptive Seized in India for Misbranding
1/12/2012
More...
|
Boston Therapeutics, Inc. Gets First Sales of SUGARDOWN™ in Italy
1/3/2012
More...
|
AstraZeneca PLC (AZN)'s Brilique is First Drug to Gain Post-AMNOG Decision in Germany
12/19/2011
More...
|
GlaxoSmithKline (GSK), Pfizer Inc. (PFE) Extend Cut-price Pneumonia Vaccine Deal
12/19/2011
More...
|
GlaxoSmithKline (GSK) Release: New Sensodyne Range Providing 24/7 Sensitivity Protection Launched in Middle East
12/12/2011
More...
|
Obama Administration Keeps Limit on Teva Pharmaceutical Industries Limited (TEVA) Morning-After Pill, Marks First Time US Overrules FDA
12/9/2011
More...
|
Ranbaxy Pharmaceuticals Inc. Launches Authorized Generic Version of Caduet® In the U.S.
12/6/2011
More...
|
Haibin Pharma Announces European Approval for Bulk Antibiotic
12/2/2011
More...
|
Ranbaxy Pharmaceuticals Inc.'s Lipitor Copy Threatens Pfizer Inc. (PFE) Sales
12/2/2011
More...
|
Novartis AG (NVS)'s Lucentis Fails to Win Backing for Eye Condition in U.K. Review
11/30/2011
More...
|
Eisai Company, Ltd. (ESALY.PK) Announce Japan Launch of Oral Anticoagulant Warfarin Granules 0.2%
11/30/2011
More...
|
Novartis AG (NVS) Halts Delivery to Second German Drug Wholesaler
11/29/2011
More...
|
Bayer AG (BAY.F) May Have Pitched Birth-Control Pill for Unapproved Use
11/23/2011
More...
|
EU Backs Boehringer Ingelheim Corporation's Pradaxa Bloodthinner, Despite Deaths
11/18/2011
More...
|
UK’s National Institute for Clinical Excellence (NICE) Rejects Eisai Inc. (ESALF.PK)'s Halaven Breast Cancer Med
11/17/2011
More...
|
Octapharma AG Reports Octagam® 5% and Octagam® 10% Global Sales Totaled 1.7 Million Grams Through October With No Thromboembolic Events
11/15/2011
More...
|
UK's National Institute for Clinical Excellence (NICE) Rejects AstraZeneca PLC (AZN) Faslodex Breast Cancer Drug
11/11/2011
More...
|
Pfizer Inc. (PFE) to Push Prevnar Vaccine Beyond Large Chinese Cities
11/10/2011
More...
|
Sanofi (France) (SASY.PA) Accelerates Development of New Lantus Formulation
11/4/2011
More...
|
Boehringer Ingelheim Corporation's Pradaxa Wins UK Backing for Stroke Prevention
11/1/2011
More...
|
Eli Lilly and Company (LLY)'s Bydureon Diabetes Drug Recommended by UK Cost Agency
10/18/2011
More...
|
Bristol-Myers Squibb Company (BMY) Skin-Cancer Drug Rejected by U.K. Cost Agency
10/14/2011
More...
|
Roche (RHHBY)'s RoActemra Wins U.K. Backing for More Arthritis Patients
10/7/2011
More...
|
MYMETICS Corporation Reclaims Innovative Intra-Nasal Influenza Vaccine
10/4/2011
More...
|
National Institute for Clinical Excellence (NICE) Rejects Sanofi (France) (SASY.PA)'s Cancer Drug Jevtana
9/30/2011
More...
|
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces the Launch of Rivastigmine Tartrate Capsules
9/22/2011
More...
|
Furiex Pharmaceuticals, Inc. (FURX) Confirms Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Launches LIOVEL(R) LD and LIOVEL(R) HD, a Fixed Dose Combination of NESINA(R) and ACTOS(R), for Type 2 Diabetes in Japan
9/21/2011
More...
|
HRA Pharma and Hyundai Pharm First Launch of ellaOne(R) in Asia
9/20/2011
More...
|
Roche (RHHBY) Keeps Drugs From Strapped Greek Hospitals, May Do the Same for Spain
9/19/2011
More...
|
UK's National Institute for Clinical Excellence (NICE) Clears AstraZeneca PLC (AZN) Brilinta Bloodthinner
9/16/2011
More...
|
Medicis (MRX) Won't Sell Fat-buster in the US Despite FDA OK
9/9/2011
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Climbs on Lipitor Launch Buzz
9/8/2011
More...
|
Dr. Reddy's Laboratories, Inc. (RDY)'s Announces the Launch of Over-the-Counter Fexofenadine HCl and Pseudoephedrine HCl Extended Release Tablets
8/31/2011
More...
|
Reckitt Benckiser Plc (RB.L) Suspects Sabotage in Mix-up of Painkiller and Antipsychotic
8/29/2011
More...
|
UK's National Institute for Clinical Excellence (NICE) Nixes AstraZeneca PLC (AZN) Breast Cancer Drug
8/24/2011
More...
|
Roche (RHHBY) Seeks $6.8 Billion Win on Heart Pill Where Pfizer Inc. (PFE) Failed
8/22/2011
More...
|
National Institute for Clinical Excellence (NICE) Backs Leukemia Drug Tasigna After Novartis AG Agrees to Discount
8/18/2011
More...
|
Uproar Over National Institute for Clinical Excellence (NICE) Rejection of Novartis AG MS Pill
8/5/2011
More...
|